Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 5/2017

01.10.2017 | Editorial

Uterus Transplant: Does It Have Legs?

verfasst von: C. V. Hegde

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Excerpt

There are essential life-saving transplants like kidney, liver, heart and bone marrow among others. A uterus transplant does not even come near and is clearly non essential. Yet eleven documented uterus transplants have been performed in three countries in human beings to date. One of these has been from a deceased donor. The most obvious reason to perform this procedure with all its comorbidities is to treat an irreversible uterine factor in infertility including Mayer Rokitansky Kuster Hauser (MRKH) syndrome, Asherman’s syndrome and an already hysterectomised patient. Uterine agenesis and hypoplasia are other causes. The treatment for a uterine factor has been adoption and surrogacy as of now. The only rationale for performing a uterus transplant seemingly is to give the woman an emotional catharsis of carrying a pregnancy till birth and affording her that ‘magical’ experience of motherhood. …
Literatur
4.
Zurück zum Zitat Zhordania IF, Gotsiridze OA. Vital activity of the excised uterus and its appendages after their autotransplantation into omentum. Experimental research. Acta Chir Plast. 1964;6:23–32.PubMed Zhordania IF, Gotsiridze OA. Vital activity of the excised uterus and its appendages after their autotransplantation into omentum. Experimental research. Acta Chir Plast. 1964;6:23–32.PubMed
5.
Zurück zum Zitat Scott JR, Pitkin RM, Yannone ME. Transplantation of the primate uterus. Surg Gynecol Obstet. 1971;133(3):414–8.PubMed Scott JR, Pitkin RM, Yannone ME. Transplantation of the primate uterus. Surg Gynecol Obstet. 1971;133(3):414–8.PubMed
9.
Zurück zum Zitat Ozkan O, Akar ME, Erdogan O, et al. Uterus transplantation from a deceased donor. Fertil Steril. 2013;100(6):e41.CrossRefPubMed Ozkan O, Akar ME, Erdogan O, et al. Uterus transplantation from a deceased donor. Fertil Steril. 2013;100(6):e41.CrossRefPubMed
11.
Zurück zum Zitat Sixty-Third World Health Assembly. World Health Organization WHO guiding principles on human cell, tissue and organ transplantation. Cell Tissue Bank. 2010;11(4):413–9.CrossRef Sixty-Third World Health Assembly. World Health Organization WHO guiding principles on human cell, tissue and organ transplantation. Cell Tissue Bank. 2010;11(4):413–9.CrossRef
12.
Zurück zum Zitat Schwarz A, Mengel M, Gwinner W, et al. Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney Int. 2005;67(1):341–8.CrossRefPubMed Schwarz A, Mengel M, Gwinner W, et al. Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney Int. 2005;67(1):341–8.CrossRefPubMed
13.
Zurück zum Zitat Stahl JE, Kreke JE, Malek FA, et al. Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis. PLoS ONE. 2008;3(6):e2468.CrossRefPubMedPubMedCentral Stahl JE, Kreke JE, Malek FA, et al. Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis. PLoS ONE. 2008;3(6):e2468.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Brannstrom M, Johannesson L, Dahm-Kahler P, et al. First clinical uterus transplantation trial: a six-month report. Fertil Steril. 2014;101(5):1228–36.CrossRefPubMed Brannstrom M, Johannesson L, Dahm-Kahler P, et al. First clinical uterus transplantation trial: a six-month report. Fertil Steril. 2014;101(5):1228–36.CrossRefPubMed
17.
Zurück zum Zitat Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus. 2004;13(9):746–50.CrossRefPubMed Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus. 2004;13(9):746–50.CrossRefPubMed
18.
Zurück zum Zitat Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2004;2004:103–14. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2004;2004:103–14.
19.
Zurück zum Zitat Briggs JD, Jager K. The first year of the new ERA-EDTA registry. Nephrol Dial Transpl. 2001;16(6):1130–1.CrossRef Briggs JD, Jager K. The first year of the new ERA-EDTA registry. Nephrol Dial Transpl. 2001;16(6):1130–1.CrossRef
20.
Zurück zum Zitat Sibanda N, Briggs JD, Davison JM, et al. Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation. 2007;83(10):1301–7.CrossRefPubMed Sibanda N, Briggs JD, Davison JM, et al. Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry. Transplantation. 2007;83(10):1301–7.CrossRefPubMed
21.
Zurück zum Zitat McKay DB, Josephson MA. Pregnancy in recipients of solid organs—effects on mother and child. N Engl J Med. 2006;354(12):1281–93.CrossRefPubMed McKay DB, Josephson MA. Pregnancy in recipients of solid organs—effects on mother and child. N Engl J Med. 2006;354(12):1281–93.CrossRefPubMed
22.
Zurück zum Zitat Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol. 2002;17(2):121–30.CrossRefPubMed Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol. 2002;17(2):121–30.CrossRefPubMed
23.
Zurück zum Zitat Akturk S, Celebi ZK, Erdogmus S, et al. Pregnancy after kidney transplantation: outcomes, tacrolimus doses, and trough levels. Transplant Proc. 2015;47(5):1442–4.CrossRefPubMed Akturk S, Celebi ZK, Erdogmus S, et al. Pregnancy after kidney transplantation: outcomes, tacrolimus doses, and trough levels. Transplant Proc. 2015;47(5):1442–4.CrossRefPubMed
Metadaten
Titel
Uterus Transplant: Does It Have Legs?
verfasst von
C. V. Hegde
Publikationsdatum
01.10.2017
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 5/2017
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-017-1037-9

Weitere Artikel der Ausgabe 5/2017

The Journal of Obstetrics and Gynecology of India 5/2017 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.